Corona Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE02ZQ01018
  • NSEID: CORONA
  • BSEID: 544644
INR
1,863.50
30.85 (1.68%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 47.99 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039887,
    "name": "Corona Remedies",
    "stock_name": "Corona Remedies",
    "full_name": "Corona Remedies Ltd",
    "name_url": "stocks-analysis/corona-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,863.50",
    "chg": 30.85,
    "chgp": "1.68%",
    "dir": 1,
    "prev_price": "1,832.65",
    "mcapval": "11,309.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544644,
    "symbol": "CORONA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE02ZQ01018",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "22:19 PM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "47.99 k",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/corona-remedies-10039887-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Corona Remedies Ltd Gains 7.82%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-gains-782-5-key-factors-driving-the-weeks-momentum-4064899",
        "imagepath": "",
        "date": "2026-06-20 09:00:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Technical momentum shifts signal mild bullish outlook</p>\n                    <p><strong>16 Jun:</strong> Momentum shifts amid sideways trend</p>\n                    <p><strong>17 Jun:</strong> New 52-week high at Rs.2,097.35 and upper circuit hit</p>\n                    <p><strong>19 Jun:</strong> Quality grade upgraded to Excellent and Mojo rating raised to Hold</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,727.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..."
      },
      {
        "title": "Corona Remedies Ltd Upgraded to Hold by MarketsMOJO on Strengthened Fundamentals and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/corona-remedies-ltd-upgraded-to-hold-by-marketsmojo-on-strengthened-fundamentals-and-technicals-4062779",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_mojoScore_4062779.png",
        "date": "2026-06-19 08:18:00",
        "description": "Corona Remedies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting significant improvements in its quality metrics and technical outlook. The pharmaceutical company’s enhanced fundamentals, coupled with a shift to a mildly bullish technical trend, have prompted analysts to revise their stance, signalling cautious optimism for investors amid a challenging sector backdrop."
      },
      {
        "title": "Corona Remedies Ltd Upgrades Quality Grade to Excellent Amid Strong Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-upgrades-quality-grade-to-excellent-amid-strong-financial-metrics-4062528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_qualitydot_4062528.png",
        "date": "2026-06-19 08:00:06",
        "description": "Corona Remedies Ltd has seen a significant upgrade in its quality grading from good to excellent, reflecting marked improvements in its core business fundamentals. The pharmaceutical company’s enhanced return ratios, robust debt management, and consistent operational performance have contributed to this positive reassessment, positioning it favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Corona Remedies Ltd Locks at Upper Circuit With 3.91% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-upper-circuit-amid-strong-buying-pressure-and-volatility-4058707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_stocks_hitting_upper_circuit_4058707.png",
        "date": "2026-06-17 10:01:44",
        "description": "At Rs 2100.7, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Corona Remedies Ltd locked at its upper circuit of 3.91% on 17 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Corona Remedies Ltd to 52-Week High of Rs 2097.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-hits-new-52-week-high-at-rs209735-4058585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_priceRelatedfactors_4058585.png",
        "date": "2026-06-17 09:57:41",
        "description": "Surging to an all-time high of Rs 2097.35 on 17 Jun 2026, Corona Remedies Ltd has demonstrated robust price momentum, outpacing its sector and marking a significant milestone in its trading history."
      },
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-mixed-market-returns-4058312",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4058312.png",
        "date": "2026-06-17 08:07:10",
        "description": "Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. Despite mixed short-term returns relative to the Sensex, the pharmaceutical and biotechnology company’s technical indicators suggest a cautiously optimistic outlook for investors."
      },
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts Amid Sideways Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-amid-sideways-trend-4055281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4055281.png",
        "date": "2026-06-16 08:08:14",
        "description": "Corona Remedies Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is reflected in key technical indicators such as MACD, RSI, and moving averages, signalling a period of consolidation after recent gains despite the stock’s strong year-to-date performance."
      },
      {
        "title": "Corona Remedies Ltd Technical Momentum Shifts Signal Mild Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-4053638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CoronaRemediesL_technicaldot_4053638.png",
        "date": "2026-06-15 08:06:01",
        "description": "Corona Remedies Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by a combination of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend for the small-cap pharmaceutical player amid a mixed market backdrop."
      },
      {
        "title": "Corona Remedies Gains 2.88%: Mixed Technical Signals and Downgrade Shape Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/corona-remedies-gains-288-mixed-technical-signals-and-downgrade-shape-weekly-moves-4051707",
        "imagepath": "",
        "date": "2026-06-13 15:01:43",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock opens at Rs.1,684.00, Sensex down 0.96%</p>\n                    <p><strong>2 June:</strong> Mojo Grade downgraded to Sell; stock closes at Rs.1,698.25 (+0.85%)</p>\n                    <p><strong>3 June:</strong> Technical momentum shifts to sideways; stock dips slightly to Rs.1,696.85 (-0.08%)</p>\n                    <p><strong>5 June:</strong> Stock rallies to Rs.1,722.75 (+1.22%) despite Sensex decline</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,674.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-..."
      }
    ],
    "total": 25,
    "sid": "10039887",
    "stock_news_url": "https://www.marketsmojo.com/news/corona-remedies-10039887"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Jun-2026",
      "details": "Newspaper Publication - Notice of 22nd Annual General Meeting Intimation of Record Date and E-voting information",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 22Nd Annual General Meeting",
      "datetime": "15-Jun-2026",
      "details": "Notice of 22nd Annual General Meeting scheduled to be held on Thursday July 09 2026",
      "source": "BSE"
    },
    {
      "caption": "Regulation 34(1)-Annual Report",
      "datetime": "15-Jun-2026",
      "details": "Annual Report for the F.Y. 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Corona Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 19 Jun 26",
          "dt": "2026-06-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Corona Remedies Ltd Gains 7.82%: 5 Key Factors Driving the Week’s Momentum

2026-06-20 09:00:54

Key Events This Week

15 Jun: Technical momentum shifts signal mild bullish outlook

16 Jun: Momentum shifts amid sideways trend

17 Jun: New 52-week high at Rs.2,097.35 and upper circuit hit

19 Jun: Quality grade upgraded to Excellent and Mojo rating raised to Hold

stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Jun-2026 | Source : BSE

Newspaper Publication - Notice of 22nd Annual General Meeting Intimation of Record Date and E-voting information

Notice Of 22Nd Annual General Meeting

15-Jun-2026 | Source : BSE

Notice of 22nd Annual General Meeting scheduled to be held on Thursday July 09 2026

Regulation 34(1)-Annual Report

15-Jun-2026 | Source : BSE

Annual Report for the F.Y. 2025-26

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Corona Remedies Ltd has declared 100% dividend, ex-date: 19 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available